2011
DOI: 10.1016/j.jep.2010.10.033
|View full text |Cite
|
Sign up to set email alerts
|

The effects of Labisia pumila var. alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
60
2
2

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 77 publications
(69 citation statements)
references
References 41 publications
2
60
2
2
Order By: Relevance
“…However, postmenopausal status is associated with an increased risk of immune disorders such as rheumatoid arthritis (D'Amelio 2013) or metabolic syndromes such as obesity due to estrogen deficiency (Kaaja 2008). A systemic skeletal disease, osteoporosis, characterized by microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and low bone mass, also resulted from menopause or estrogen deficiency (Shuid et al 2011). Estrogen is a well-known regulator of bone metabolism, postmenopausal osteoporosis, and the morbidity which are major health problems in elderly women (Melton et al 2004).…”
Section: Introductionmentioning
confidence: 99%
“…However, postmenopausal status is associated with an increased risk of immune disorders such as rheumatoid arthritis (D'Amelio 2013) or metabolic syndromes such as obesity due to estrogen deficiency (Kaaja 2008). A systemic skeletal disease, osteoporosis, characterized by microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and low bone mass, also resulted from menopause or estrogen deficiency (Shuid et al 2011). Estrogen is a well-known regulator of bone metabolism, postmenopausal osteoporosis, and the morbidity which are major health problems in elderly women (Melton et al 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Pharmacological studies carried out on M. pumilum have reported a wide range of biologic activities in laboratory animals. These include: estrogenic (Husniza, 2002;Fazliana et al, 2009;Ayida et al, 2007), antioxidant (Norhaiza et al, 2009), antiasthmatic (Ekeuku and Okechukwu, 2012), anti-inflammatory (Choi et al, 2010, antihistaminic, antinociceptive and antiulcer Marunga, 2011, Okechukwu andEkeuku, 2012), cytotoxic (AlMekhalafi et al, 2012), antihyperlipidemic (George et al, 2014) skin protective (Chua et al, 2011), weight reduction (Pandey et al, 2104) and osteoprotective (Shuid et al, 2011) properties.…”
Section: Marantodes Pumilummentioning
confidence: 99%
“…Measuring these markers can also be used to provide useful clinical information on bone turnover rate, bone health and as a complimentary diagnostic tool to BMD (Johnell et al, 2002). In a study published in 2011 (Shuid et al, 2011), bone biomarkers and total calcium contents were investigated in eight (8) weeks M. pumilum root extract supplemented ovariectomized rats. The study revealed significantly higher levels of osteocalcin (a bone formation marker) and lower C-terminal telopeptide of type 1 collagen, CTX-1 (a bone resorption marker) in the group that received 17.5 mg/kg/day M. pumilum than in ovariectomized control group.…”
Section: Effects On Bone Turnover Markersmentioning
confidence: 99%
See 1 more Smart Citation
“…Berdasarkan penelitian Shuid et al (2011), bahwa hasil marker biokimia tulang menunjukkan perubahan karakteristik osteoporosis pada tikus ovariektomi. Osteokalsin merupakan protein non kolagen yang disintesis oleh osteoblas dan pada umumnya dianggap sebagai marker spesifik untuk aktivitas osteoblastik dan untuk pembentukan tulang.…”
Section: Metodeunclassified